Performance Measure for 7 days | PAMG-1 | phlIGFBP-1 | CL (<25 mm) |
Sensitivity (SN) Proportion Confidence Interval | 83% (5/6) (35.88, 99.58) | 83% (5/6) (35.88, 99.58) | 100% (6/6) (54.07, 100) |
Specificity (SP) Proportion Confidence Interval | 90%* (46/51) (78.59, 96.74) | 76% (39/51) (62.51, 87.21) | 71% (36/51) (56.17, 82.51) |
Positive Predictive Value (PPV) Proportion Confidence Interval | 50% (5/10) (18.71, 81.29) | 29% (5/17) (10.31, 55.96) | 29% (6/21) (11.28, 52.17) |
Negative Predictive Value (NPV) Proportion Confidence Interval | 98% (46/47) (88.71, 99.95) | 98% (39/40) (86.84, 99.94) | 100% (36/36) (90.26, 100) |
Performance Measure for 14 days | PAMG-1 | phlIGFBP-1 | CL (<25 mm) |
Sensitivity (SN) Proportion Confidence Interval | 67% (6/9) (29.93, 92.51) | 67% (6/9) (29.93, 92.51) | 78% (7/9) (39.99, 97.19) |
Specificity (SP) Proportion Confidence Interval | 92% (44/48) (80.02, 97.68) | 77% (37/48) (62.69, 87.97) | 71% (34/48) (55.94, 83.05) |
Positive Predictive Value (PPV) Proportion Confidence Interval | 60% (6/10) (26.24, 87.84) | 35% (6/17) (14.21, 61.67) | 33% (7/21) (14.59, 56.97) |
Negative Predictive Value (NPV) Proportion Confidence Interval | 94% (44/47) (82.46, 98.66) | 93% (37/40) (79.61, 98.43) | 94% (34/36) (81.34, 99.32) |